Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07193056 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

The CPH-MBD Cohort

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Recruitment opened Show 5 more changesShow less
    • Study sites: 0 to 1
    • Start date changed from estimate of Dec 2025 to Jan 7, 2026
    • Secondary endpoints: details revised at 1 of 7 entries
    • Publications: details revised at 21 of 21 entries
    • Eligibility criteria expanded, about 3 words
  2. Start date: Oct 2025 to Dec 2025
    • Secondary endpoints: 5 to 7
    • Study description expanded, about 21 words
    • Study arms: 1 to 2
    v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Persons with chronic kidney disease (CKD) have a 3-fold increased risk of bone fracture and a 10-fold increased risk of cardiovascular disease than the general population. These increased risks are related to the disturbances in the mineral metabolism, and this clinical entity is termed Chronic Kidney Disease - Mineral and Bone Disorder (CKD-MBD). The overall aim of the present project is to explore factors that may predict or associate with the development of bone and cardiovascular disease in patients with CKD and hopefully provide insight into underlying mechanisms and pathophysiological pathways for future treatment and prevention. In a sub study investigators aim to explore the calcium and phosphate balance in patients with CKD and describe how these associate with each other as well as with kidney function (eGFR).
Trial Details
NCT Number NCT07193056
Lead Sponsor Herlev Hospital
Conditions
(from sponsor)		 Chronic Kidney Disease Mineral and Bone Disorder, Chronic Kidney Disease (CKD), Bone Markers
Related terms Chronic Kidney Disease-Mineral and Bone Disorder, Renal Insufficiency, Chronic
Enrollment 1,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov